A report published by the Sustainable Healthcare Coalition44 estimated that the greenhouse gas (GHG) emissions associated with a person’s management of severe asthma is reduced by approximately 50% through the use of mAb therapy.

This reduction is due to the combined effects of improved symptom control, reduced exacerbations and a decrease in hospital admissions.

These trends directly affect the environmental impact associated with asthma management and are important steps towards more sustainable treatment.